Count | |
| 6 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 11 | |
| 1 | |
| 22 | |
| 16 | |
| 1 | |
| 10 | |
| 9 | |
| 1 | |
| 23 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 2 | |
| 4 | |
| 1 | |
| 15 | |
| 2 | |
| 2 | |
| 4 | |
| 18 | |
| 17 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 2 | |
| 6 | |
| 12 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 4 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Vasopressins/antagonists & inhibitors/biosynthesis/*metabolism | 1 |
| 2 | |
Vasopressins/*antagonists & inhibitors/pharmacology/physiology | 1 |
| 1 | |
Vasopressins/administration & dosage/adverse effects/*therapeutic use | 1 |
Vasopressins/*antagonists & inhibitors/*chemical synthesis/chemistry | 1 |
Promoter Regions (Genetics)/drug effects/*genetics/physiology | 1 |
Trans-Activation (Genetics)/drug effects/genetics/physiology | 1 |
Promoter Regions (Genetics)/drug effects/genetics/immunology | 1 |
Trans-Activation (Genetics)/drug effects/genetics/*physiology | 1 |
Promoter Regions (Genetics)/drug effects/genetics/*physiology | 4 |
Promoter Regions (Genetics)/drug effects/genetics/physiology | 8 |
| 1 | |
| 1 | |
Antisense Elements (Genetics)/genetics/metabolism/*pharmacology | 1 |
| 8 | |
| 31 | |
| 5 | |